Page 3 - Aneeka Chatterjee

Embassy Developments to launch 6 residential projects valued at ₹10,300 cr

The developer plans six residential launches and a ₹5,000 crore pre-sales target as demand stays strong in the city's northern market

Labour codes: Real estate expects up to 10% spike in baseline labour cost

Developers expect short-term cost and timeline pressures, but say unified labour laws will bring predictability, better compliance and steadier workforce availability

UBL finalises lease registration for brewery in UP, invests ₹750 crore

This expansion will be financed through debt and equity, it said in its exchange filing

Stylework raises ₹30 crore in pre-Series B round to scale operations

Workspace aggregator Stylework has secured Rs 30 crore in pre-Series B funding to boost its tech platform, expand across markets and strengthen leadership hiring amid rapid growth in India's flexible

BioE3 Mission highlights scale, collaboration in India's biotech drive

Industry leaders at the Bengaluru Tech Summit said India's BioE3 Mission can succeed only with rapid scale-up, stronger industry-academia partnerships and sharper focus on downstream capacity

Must target biotech sovereignty by 2047: Biocon's Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw urges India to achieve 'biotech sovereignty' by 2047, driven by a $330 bn bioeconomy, BioE3 framework, scale exports, a sovereign AI stack, and crucial R&D investment

Serene Communities, Asset Homes to build 4 senior-living projects in Kerala

Serene Communities by Columbia Pacific has partnered with Asset Homes to invest Rs 500 crore in four senior-living projects across Kerala

Puravankara leases retail space to IKEA at Purva Zentech Park in Bengaluru

The retailer will open its second Bengaluru store at Puravankara's upcoming Kanakapura Road project, set to be handed over in early 2026

Jaguar Land Rover expands Bengaluru office space with ₹106 cr, 5-year deal

Luxury car major's tech hub to widen GCC presence in India

Craft spirits pour new energy into India's alcobev giants as demand rises

India's craft spirits boom is reshaping alcohol M&A as major players snap up boutique gin and vodka brands to attract young consumers, drive premiumisation and expand in fast-growing niches

Macroeconomic tailwinds to lift sentiment in India's realty sector: Report

India's real estate outlook remains upbeat as easing inflation, fiscal spending, premium housing demand, and strong office leasing fuel confidence, according to the Knight Frank-Naredco

ICL Fincorp to launch ₹100 crore NCD issue offering 12.62% effective yield

The issue has a base size of Rs 50 crore and a green-shoe option of Rs 50 crore. The instruments are rated BBB- by domestic rating agency Crisil

Debt restructuring to reduce interest costs by ₹300 cr by FY27: Biocon CEO

CEO Shreehas Tambe says debt reduction, US state tie-ups, and five fresh product launches will strengthen Biocon Biologics' global biosimilar play

Puravankara to invest ₹7,000 cr in new housing projects across India

Puravankara plans to invest ₹7,000 crore in upcoming residential projects expected to generate ₹15,000 crore in sales, expanding its presence beyond southern markets

Biocon Q2FY26 results: Consolidated net profit at ₹84.5 cr, revenue up 21%

The biosimilars segment, operated by Biocon Biologics, reported revenues of Rs 2,721 crore, reflecting strong 25 per cent year-on-year growth

PharmEasy report finds 1 in 2 Indians tested have high blood sugar

Half of India's HbA1c test results fall in the diabetic range, PharmEasy report finds, warning of a growing diabetes crisis driven by lifestyle, regional, and gender disparities

India's spirits industry braces up cautiously ahead of UK FTA ratification

With tariff cuts under the UK-India FTA, spirit producers expect faster growth, price access, and stiffer competition in premium whisky

Technology to disrupt every aspect of healthcare: Narayana Health founder

Narayana Health's founder Devi Shetty says UK acquisition of Practice Plus Group will help integrate technology-driven efficiency into global healthcare, as the group prepares its next growth phase

Allied Blenders plans double-digit growth, higher margins by FY27

Allied Blenders plans to invest Rs 547 crore to strengthen backward integration, expand globally, and grow its premium and luxury portfolio, aiming for higher margins and sustainable growth

Biocon arm Syngene eyes late-stage clinical supplies amid regulatory shift

As regulators ease biosimilar trial norms, Syngene International is expanding into late-stage clinical supply production, betting on biologics and peptide manufacturing for growth